AzTrials
AzTrials

Deep Gluteal SyndromeBowen+ESWTNCT07772661

Comparative Effects of the Bowen Technique With and Without Extracorporeal Shock Wave Therapy in Patients With Deep Gluteal Syndrome

A study testing Experimental : Group A = Bowen With ESWT in people with Deep Gluteal Syndrome, run by University of Management and Technology Sialkot Pakistan at 1 site in Pakistan.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

A single-blinded, randomized controlled trial consisting of 46 participants with Deep Gluteal syndrome, calculated by the G power tool with an attrition rate of 5 % will be conducted. Participants will be recruited using non-probability convenience sampling based on pre-defined inclusion and exclusion criteria. Read more about this study

Who is it for?
Ages 25 to 45 years
Conditions the study is for
Deep Gluteal Syndrome
What is being tested?
Experimental : Group A = Bowen With ESWT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 sitePakistan
Study dates
1 May 2026to 1 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Individuals aged 25 to 45 years, including both genders 55
  • Positive FAIR, Active Piriformis Test, Seated Piriformis Stretch Test 56,6,57
  • NPRS pain score ≥ 3/10 55
  • For a minimum of four weeks, there has been unilateral discomfort in the buttock, with or without accompanying posterior thigh pain, exacerbated by sitting 58

Who cannot join

  • Previous surgery involving the ipsilateral hip, pelvis, lumbar spine, or sacroiliac joint 34
  • Women who were pregnant or nursing were excluded 59
  • Medical conditions such as tumors or fractures 60
  • Neuromuscular disorders that impair normal lumbopelvic morphology or progressive neurologic disease 60
  • Disc pathologies identified through radiological imaging 17
  • Pathologies of the hip joint and soft tissues 17
Show all 9Show fewer
  • Recent trauma history 17
  • History of polyneuropathy, sciatic nerve injury, rheumatological disease, or malignancy 17
  • Corticosteroid therapy or opioid-derived analgesia for pain during the previous month 17

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pakistan1 site
  • University of Management and technology Sialkot Campus

    Sialkot, Punjab Province, 51070

Other trials in Pakistan

About this study

Official title: Comparative Effects of the Bowen Technique With and Without Extracorporeal Shock Wave Therapy in Patients With Deep Gluteal Syndrome: A Randomized Clinical Trial

A single-blinded, randomized controlled trial consisting of 46 participants with Deep Gluteal syndrome, calculated by the G power tool with an attrition rate of 5 % will be conducted. Participants will be recruited using non-probability convenience sampling based on pre-defined inclusion and exclusion criteria. Participants will be randomly assigned into two groups with 23 participants each group. Group A will receive Bowen Technique with extracorporeal shockwave therapy. Group B will receive Bowen Technique without extracorporeal shockwave therapy in conjunction with conventional therapy. Primary outcomes like pain, functional level and ROM will be measured at baseline and post-intervention using the Lower extremity functional scale (LEFS), Numeric Pain Rating scale (NPRS), and Goniometer. Data will be analyzed by IBM SPSS 26.0 with the Shapiro-Wilk test to confirm the normality.

Read the detailed description

This randomized controlled trial investigates the effects of Bowen Technique with and without Extracorporeal Shockwave Therapy in patients with Deep Gluteal Syndrome. The study includes 46 participants, with 23 participants allocated to each group. Group A receives Bowen Technique combined with ESWT, while Group B receives Bowen Technique without ESWT, with both groups receiving standardized physiotherapy. The main outcomes assessed are pain intensity, lower-limb function, hip range of motion, and clinical provocation tests including the FAIR Test, Active Piriformis Test, and Seated Piriformis Stretch Test. NPRS, LEFS, universal goniometry, and the clinical special tests are used to evaluate changes from baseline to post-treatment. The study aims to determine whether adding ESWT to Bowen Technique provides greater clinical benefit than Bowen Technique alone in patients with Deep Gluteal Syndrom

Being tested
Experimental : Group A = Bowen With ESWT, Control Group: Group B= Bowen Techniques only
Keywords
Bowen therapy, Deep gluteal syndrome, Extracorporeal Shockwave Therapy
Medical subject headings
Hip socket neuropathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental : Group A = Bowen With ESWTOther

    Bowen Technique is a gentle manual fascial technique used to reduce muscle tension, pain, and soft-tissue restriction. ESWT is a non-invasive mechanical treatment that delivers shockwaves to promote analgesia, circulation, and tissue repair. In Deep Gluteal Syndrome, both can target the painful and restricted deep gluteal tissues, so my study compares Bowen alone with Bowen combined with ESWT to determine whether the addition of ESWT provides greater clinical benefit

  • Control Group: Group B= Bowen Techniques onlyOther

    The Bowen Technique is a gentle manual soft-tissue technique developed by Thomas Bowen. It uses slow, precise, cross-fiber rolling movements over muscles, tendons, ligaments, and fascia, with short rest periods between sets of movements. In your study, the therapist applies gentle pressure to the deep gluteal muscles, holds the tissue briefly, then moves across it in a controlled manner.

Study groups in NCT07772661
Study groupRoleWhat they receive
GROUP A (Bowen Technique with ESWT)ExperimentalGroup A will receive Bowen Technqiue with ESWT along with conventional Physiotherapy Protocol.
Receives: Other: Experimental : Group A = Bowen With ESWT
GROUP B (Bowen technique without ESWT)Active comparatorGroup B will receive Bowen Technqiue ONLY along with conventional Physiotherapy Protocol.
Receives: Other: Control Group: Group B= Bowen Techniques only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. UNIVERSAL GONIOMETRY

    A goniometer is a conventional clinical tool utilized to assess joint range of motion (ROM), offering objective and dependable measurements to assess mobility restrictions in musculoskeletal disorders72

    . Goniometric measurement of passive hip ROM has good test-retest reliability, with

    ICC ranging from 0.82 to 0.94 across different hip movements79

    • For goniometric evaluation of hip internal rotation, the minimal detectable change (MDC) is 8.6°, and for hip external rotation, it is 6.1° 18
    • According to anchor-based methodology, the minimal clinically significant difference (MCID) for hip range of motion is 5.81° 80

    Measured: 6 Weeks

  2. NUMERICAL PAIN RATING SCALE (NPRS)

    The Numeric Pain Rating Scale (NPRS) is a self-reported metric utilized to evaluate pain severity in individuals with musculoskeletal conditions 70

    • It is a simple 11-point scale that ranges from 0 (no pain) to 10 (worst pain imaginable) that can be administered verbally or in writing 74
    • which shows multilevel likelihood ratios of 0.99 (scores 1-3), 2.67 (scores 4-6), and 5.60 (scores 7-10) for detecting pain-related functional interference, and an established sensitivity of 69 percent at ascore of 175 .Patients are asked to rate their current, best, and worst pain levels during the previous 24 hours, and the average of the three values is used to get the final pain intensity score 76 The NPRS minimal clinically significant difference (MCID) in this current study was set at two points 77 . The NPRS is widely used in research and clinical environments due to its ease of use, high reliability, validity, and responsiveness to clinically relevant changes in both acute and chronic

    Measured: 6 Weeks

Secondary outcomes (1)
  1. LEFS

    The Lower Extremity Functional Scale (LEFS) is a patient-reported outcome measure utilized to evaluate functional impairments in individuals with lower extremity musculoskeletal disorders 71

    . There are twenty items in the LEFS, and the scores range from 0 (extreme difficulty/unable to perform activity) to 4 (no difficulty). By adding up the scores for each item, the overall score can be found. Extreme limitations are indicated by a score of 0, while a maximum score of 80 denotes no functional limitations82

    • When compared to the SF-36, the LEFS's construct validity was confirmed, and its sensitivity to change was higher than the SF-36's.The subgroup of patients with more chronic conditions showed excellent test-retest reliability (r = 0.94; 95 percent lower limit CI = 0.89) 71
    • When tested against the Timed Up and Go (TUG) test as an external criterion, the LEFS showed exceptional diagnostic accuracy with a sensitivity of 92% and specificity of 96% at a cut-off score of 53

    Measured: 6 Weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2026
  2. Study start1 May 2026
  3. Primary completion25 Jun 2026
  4. Study completion1 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study uses a randomized controlled trial model to compare two physiotherapy interventions for Deep Gluteal Syndrome. A total of 46 participants are divided equally into two groups of 23 participants each. Group A receives Bowen Technique with Extracorporeal Shockwave Therapy, while Group B receives Bowen Technique without ESWT. Pain, lower-limb function, hip range of motion, and relevant clinical special tests are assessed before and after treatment. The model is designed to determine whether adding ESWT to Bowen Technique provides greater clinical improvement than Bowen Technique alone.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
46 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07772661
Sponsor's protocol ID
kuhs/dpt/umt-skt-00261
Acronym
Bowen+ESWT
Status last verified
Aug 2026
First submitted
10 Aug 2026
Last updated
21 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Amjad F, Khalid A. Comparative effects of Bowen therapy and tennis ball technique on pain and functional disability in patients with thoracic myofascial pain syndrome. J Orthop Surg Res. 2023 Nov 24;18(1):895. doi: 10.1186/s13018-023-04379-z.

    PubMed 37996838
  • De la Corte-Rodriguez H, Roman-Belmonte JM, Rodriguez-Damiani BA, Vazquez-Sasot A, Rodriguez-Merchan EC. Extracorporeal Shock Wave Therapy for the Treatment of Musculoskeletal Pain: A Narrative Review. Healthcare (Basel). 2023 Oct 26;11(21):2830. doi: 10.3390/healthcare11212830.

    PubMed 37957975
  • Kurkova S, Kyncl M, Ibrahim I, Lachman H, Sakmarova K, Machac S. Exploring non-invasive diagnostic tools for deep gluteal syndrome: a multimodal approach integrating clinical and imaging techniques. Quant Imaging Med Surg. 2025 Sep 1;15(9):8409-8422. doi: 10.21037/qims-2025-241. Epub 2025 Aug 13.

    PubMed 40893505
  • Carro LP, Hernando MF, Cerezal L, Navarro IS, Fernandez AA, Castillo AO. Deep gluteal space problems: piriformis syndrome, ischiofemoral impingement and sciatic nerve release. Muscles Ligaments Tendons J. 2016 Dec 21;6(3):384-396. doi: 10.11138/mltj/2016.6.3.384. eCollection 2016 Jul-Sep.

    PubMed 28066745

Questions about this trial

What is this clinical trial studying?

A study testing Experimental : Group A = Bowen With ESWT in people with Deep Gluteal Syndrome, run by University of Management and Technology Sialkot Pakistan at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

UNIVERSAL GONIOMETRY (time frame: 6 Weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07772661, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in